Paulson & CO. Inc. purchased a new position in Monsanto Company (NYSE:MON) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 35,500 shares of the basic materials company’s stock, valued at approximately $4,019,000.
Other large investors also recently modified their holdings of the company. First PREMIER Bank increased its stake in shares of Monsanto by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock worth $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. boosted its stake in Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares during the last quarter. Hartford Financial Management Inc. acquired a new stake in Monsanto during the first quarter valued at $113,000. Acrospire Investment Management LLC acquired a new stake in Monsanto during the first quarter valued at $113,000. Finally, JNBA Financial Advisors boosted its stake in Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the last quarter. 75.31% of the stock is currently owned by institutional investors and hedge funds.
Shares of Monsanto Company (MON) opened at 116.55 on Friday. The firm’s 50-day moving average price is $117.47 and its 200-day moving average price is $115.08. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The firm has a market capitalization of $51.20 billion, a P/E ratio of 25.17 and a beta of 1.07.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.17 earnings per share. On average, equities analysts forecast that Monsanto Company will post $4.89 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s payout ratio is presently 46.75%.
Several equities research analysts have weighed in on MON shares. Citigroup Inc. restated a “neutral” rating and set a $125.00 target price (up from $122.00) on shares of Monsanto in a research note on Friday, April 14th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a research note on Friday, June 16th. BidaskClub cut Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Thursday, July 6th. Finally, Susquehanna Bancshares Inc restated a “neutral” rating and set a $128.00 target price (up from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have given a buy rating to the stock. Monsanto currently has a consensus rating of “Hold” and an average price target of $123.15.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock worth $8,791,281 over the last quarter. Insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.